Template:CLINDAMYCIN HYDROCHLORIDE: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...")
 
No edit summary
 
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[clindamycin hydrochloride|{{fontcolor|#6C7B8B|clindamycin hydrochloride}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Clindamycin hydrochloride|{{fontcolor|#6C7B8B|Clindamycin hydrochloride}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CLEOCIN HYDROCHLORIDE<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CLEOCIN HYDROCHLORIDE<sup>®</sup> FDA Package Insert
Line 21: Line 21:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride directions for use|Directions for Use]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[clindamycin hydrochloride how supplied|How Supplied]]

Latest revision as of 17:12, 9 January 2014